Concise Prescribing Info
Medroxyprogesterone acetate
Dosage/Direction for Use
150 mg every 3 mth by deep IM inj (1st inj is administered during the 1st 5 days of normal menstrual period or before the 6th wk postpartum).
Hypersensitivity. Vag bleeding of unknown cause; pathological signs of the breast/s; urinary tract bleeding of unknown cause. Pregnancy.
Special Precautions
Re-evaluate use in the presence of thromboembolic disorder signs &/or symptoms. Evaluate to exclude papilledema or retinal vascular lesions before continuing treatment in those who develop acute impairment of vision, proptosis, diplopia, migraine. Monitor for anaphylactic & anaphylactoid reactions. Amenorrhea & anovulation may persist for periods up to 18 mth, in rare cases for longer periods, after administration for several times. Carry out breast & pelvic organ exam including Pap smear before use. Careful administration for patients w/ epilepsy, migraines, asthma, cardiac or renal dysfunction due to risk of fluid retention. Consider organic causes & carry out a diagnostic exam in case of breakthrough bleeding. Patients w/ mental depression history; diabetes. Body wt may increase. May affect laboratory tests [eg, levels of plasma gonadotropin, progesterone, estrogen (in female) & cortisol, urinary pregnanediol; glucose tolerance test]; endocrine & liver function tests; mask the onset of the climacteric symptom. Not recommended for treatment of secondary amenorrhea or dysfunctional uterine bleeding.
Adverse Reactions
Anaphylactic reaction; thrombophlebitis & pulmonary embolism; insomnia, nervousness, fatigue, depression, dizziness & headache; urticaria, pruritus, skin rash, acne, hirsutism & alopecia; nausea; breast tenderness & galactorrhea; changes in cervical erosion & secretions; hyperpyrexia, changes in bodywt or development of moonfacies; pain, change in skin colour & residual lump at inj site.
MIMS Class
Depot Contraceptives
ATC Classification
G03AC06 - medroxyprogesterone ; Belongs to the class of progestogens. Used as systemic contraceptives.
Andalan susp for inj 150 mg/3 mL
20 × 1's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in